Today, SkyCell -- one of the companies that built containers to transport these medicines, along with many other un-shelf stable pharmaceuticals that are used to treat a variety of conditions -- is announcing a big round of funding to fuel its growth. The funding comes as SkyCell reaches new heights of its own, so to speak: it's now transporting $1.5 billion of pharmaceutical products each month (finished and raw materials). Ironically, despite the startup's role in helping move around vaccines, the peak of the pandemic years were not the best for SkyCell's growth: because everything else effectively halted in terms of medical care, and supply chains slowed down significantly, so too did SkyCell's business.